MERTK is a potential therapeutic target in osimertinib-resistant non-small cell lung cancer

被引：1
|
作者：
Yan, Dan [1 ]
Huelse, Justus [1 ]
Parker, Rebecca [1 ]
Wang, Xiaodong [2 ]
Frye, Stephen V. [2 ]
Earp, H. Shelton [3 ]
DeRyckere, Deborah [1 ]
Graham, Douglas [1 ]
机构：
[1] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA
[2] Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA
[3] Sch Med, Chapel Hill, NC USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-4765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4765
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Characterization of circRNAs in established osimertinib-resistant non-small cell lung cancer cell lines
    Chen, Xin
    Gu, Jingyao
    Huang, Jiali
    Wen, Kang
    Zhang, Ge
    Chen, Zhenyao
    Wang, Zhaoxia
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2023, 52 (05)
  • [2] Identification of super-enhancer-driven peptidyl arginine deiminases as potential biomarkers and therapeutic targets for osimertinib-resistant non-small cell lung cancer
    Li, Hang
    Muhetaer, Gulizeba
    Xie, Yizi
    Yao, Kainan
    Ma, Qianqian
    Guan, Huiting
    Xing, Sizhong
    Huang, Xiufang
    Zhou, Jihong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer
    Han, Ruoshuang
    Guo, Haoyue
    Shi, Jinpeng
    Zhao, Sha
    Jia, Yijun
    Liu, Xiaozhen
    Liu, Yiwei
    Cheng, Lei
    Zhao, Chao
    Li, Xuefei
    Zhou, Caicun
    BMC MEDICINE, 2024, 22 (01)
  • [4] Immunoproteasome as a Potential Therapeutic Target in Cisplatin-Resistant Small and Non-Small Cell Lung Cancer
    Shoji, T.
    Kikuchi, E.
    Kikuchi, J.
    Maeda, M.
    Takashima, Y.
    Furuta, M.
    Takahashi, H.
    Kinoshita, I.
    Dosaka-Akita, H.
    Sakakibara-Konishi, J.
    Konno, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S705 - S705
  • [5] Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines
    Codony-Servat, Jordi
    Viteri, Santiago
    Codony-Servat, Carles
    Ito, Masaoki
    Paulina Bracht, Jillian Willhelmina
    Berenguer, Jordi
    Chaib, Imane
    Angel Molina-Vila, Miguel
    Karachaliou, Niki
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (04) : 340 - 351
  • [6] Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial
    Satoru Miura
    Yasuhiro Koh
    Koichi Azuma
    Hiroshige Yoshioka
    Kenichi Koyama
    Shunsuke Teraoka
    Hidenobu Ishii
    Kayoko Kibata
    Yuichi Ozawa
    Takaaki Tokito
    Jun Oyanagi
    Toshio Shimokawa
    Takayasu Kurata
    Nobuyuki Yamamoto
    Hiroshi Tanaka
    BMC Cancer, 23
  • [7] Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial
    Miura, Satoru
    Koh, Yasuhiro
    Azuma, Koichi
    Yoshioka, Hiroshige
    Koyama, Kenichi
    Teraoka, Shunsuke
    Ishii, Hidenobu
    Kibata, Kayoko
    Ozawa, Yuichi
    Tokito, Takaaki
    Oyanagi, Jun
    Shimokawa, Toshio
    Kurata, Takayasu
    Yamamoto, Nobuyuki
    Tanaka, Hiroshi
    BMC CANCER, 2023, 23 (01)
  • [8] Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer
    Shoji, Tetsuaki
    Kikuchi, Eiki
    Kikuchi, Junko
    Takashima, Yuta
    Furuta, Megumi
    Takahashi, Hirofumi
    Tsuji, Kosuke
    Maeda, Makie
    Kinoshita, Ichiro
    Dosaka-Akita, Hirotoshi
    Sakakibara-Konishi, Jun
    Konno, Satoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (05) : 843 - 853
  • [9] Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer
    Tetsuaki Shoji
    Eiki Kikuchi
    Junko Kikuchi
    Yuta Takashima
    Megumi Furuta
    Hirofumi Takahashi
    Kosuke Tsuji
    Makie Maeda
    Ichiro Kinoshita
    Hirotoshi Dosaka-Akita
    Jun Sakakibara-Konishi
    Satoshi Konno
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 843 - 853
  • [10] Novel lignans from Zanthoxylum nitidum and antiproliferation activity of sesaminone in osimertinib-resistant non-small cell lung cancer cells
    Wang, Cai Yi
    Qin, Feng
    Wang, Chun-Gu
    Kim, Donghwa
    Li, Jin-Jun
    Chen, Xian-Lan
    Wang, Heng-Shan
    Lee, Sang Kook
    BIOORGANIC CHEMISTRY, 2023, 134
12345